A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome

NCT03651726 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Tourette Syndrome

Interventions

DRUG: THX-110 (dronabinol plus PEA)
DRUG: Placebo

Sponsor

Neurothera Labs Inc.

Collaborators

[object Object]